The methanol extract from the stem bark of Terminalia superba (TSB), fractions (TSB1 -7) and two compounds isolated following bio-assay guided fractionation namely 3,4'- 
Material and methods

Plant material
The stem bark of Terminalia superba Engl. & Diels was collected from Ebolowa, Southern region of Cameroon, in June 2004. The plant was identified at the Cameroon National Herbarium, Yaounde, (by Mr. Victor Nana) where a voucher specimen (W.C.S. 3642a/12543/Ya) was deposited.
Extraction and bio-assay guided purification
The air-dried, free from endotoxin and powdered stem bark (1.5 Kg) of T. superba was extracted by maceration in methanol (6 L) at room temperature for 48 h. The filtrate was then concentrated under vacuum to give a dark crude extract (TSB) (73 g). The extract (55 g) was subjected to a silica gel-60 column chromatography and eluted with hexane-ethyl acetate (hex-EtOAc) and ethyl acetate-methanol (EtOAc-MeOH) gradients. One hundred and forty five fractions of 150 ml each were collected as follows: hex (1-12), hex-EtOAc 75:25 (13-38), hex-EtOAc 50:50 (39-55), hex-EtOAc 25:75 (56-77), EtOAc (78-91), , . These fractions were then pooled following analytic TLC in seven new fractions: TSB1 (1-8; 1.8 g), TSB1 (9-26; 2.1 g), TSB3 (27-42; 3.2 g), TSB4 (43-61; 3.6 g), 5.4 g), 11.5 g), 15.8 g) . On the basis of the antimicrobial investigations of the above fractions, TSB6 and TSB7 were each subjected to a second column chromatography. Eight grams of TSB6 were passed through Sep-Pak C 18 -cartridges (15 g) using H 2 O-MeOH and CHCl 3 as solvent to yield a grey powder identified as ellagic acid (C 14 H 6 O 8 ) (3; 16 mg, Mw: 302.20, mp 361-362°C) (Grzegorz and Jaromir, 1996) 
General procedure
IR spectra were recorded on an ATI Mattson Genesis Series FTIR spectrometer as KBr disc.
1 H-NMR, 13 C-NMR, two-dimensional COSY, ROESY, HSQC and HMBC analysis were performed on a Bruker Avance DPX instrument (300 MHz and 500 MHz for 1 H and 75
MHz for 13 C). The 2.50 and 40.0 ppm resonances of residual CD 3 SOCD 3 were used as internal references for 1 H and 13 C-NMR spectra, respectively. Mass spectra were recorded on a micro TOF instrument. All melting points were determined on a micro-melting point apparatus and are uncorrected. The structures of the compounds were confirmed by comparing with reference data from available literature. 
Microbial strains
Microplate susceptibility testing against Mycobacterium smegmatis
All samples were tested against Mycobacterium smegmatis using the microplate dilution method. The MIC, MMC and bacteria preparation were performed in 96-well microplates according to Salie et al. (1996) and Newton et al. (2002 Africa) and incubated at 37°C for 30 min (Eloff, 1998; Mativandlela et al., 2006) . Viable bacteria reduced the yellow dye to pink. MIC was defined as the lowest sample concentration that prevented this change and exhibited complete inhibition of bacterial growth. The MMC was determined by adding 50 µl aliquots of the preparations (without INT), which did not show any growth after incubation during MIC assays, to 150 µl of 7H9 broth. These preparations were incubated at 37°C for 48 h. The MMC was regarded as the lowest concentration of extract, which did not produce a color change after addition of INT as mentioned above.
Antituberculosis Activity: MABA susceptibility testing
The activity of all samples against M. tuberculosis was tested using the microplate Alamar Blue assay (MABA) according to Collins and Franzblau (1997) 
Determination of Mycobactericidal Effect (MMC)
Samples with detected MIC values with MABA (Collins and Franzblau 1997, Jimenez-Arellanes et al. 2003) were assayed for their mycobactericidal effect as follows. Two six-well rows of a microplate were prepared with fresh Middlebrook 7H9 culture medium.
Two-fold dilution series of the experimental sample and inoculum were set up as previously described, but only one six-well row was used to confirm the MIC value with Alamar Blue.
Immediately thereafter, 5 µl of the undeveloped mycobacterial suspensions were transferred from the former to a new microplate that contained 195 µl of fresh culture medium per well.
Three wells were inoculated with 100 µl of fresh inoculum as for MABA and three more wells were incubated with 200 µl of culture medium only (as negative controls). The microplates were incubated and developed with Alamar Blue as for MABA. The minimal bactericidal concentration (MMC) corresponded to the minimum sample concentration that did not cause a color shift in cultures re-incubated in fresh medium.
Preparation of discs
Whatmann filter paper (N° 1) discs of 6 mm diameter were impregnated with 10 µl of the crude extract solution at 10 mg/ml (100 µg/disc), fractions and isolated compounds at 4 mg/ml (40 µg/disc) prepared using DMSO. The discs were evaporated at 37°C for 24 hours.
The RA discs and SA were prepared as described above using the appropriate concentrations to obtain discs containing 40 µg and 100 µg of drug respectively. Two discs were prepared for each sample.
Diffusion test
The antimicrobial diffusion test was carried out as described by Jorgensen et al.
(1999) using a cell suspension of about 1.5 10 6 CFU/ml obtained from a McFarland turbidity standard N° 0.5. The suspension was standardized by adjusting the optical density to 0.1 at 600 nm (SHIMADZU UV-120-01 spectrophotometer) (Kuete et al., 2007a, b) . This was used to inoculate, by flooding, the surface of MHA plates. Excess liquid was air-dried under a sterile hood and the impregnated discs were applied at equidistant points on top of the agar medium. A disc prepared with only the corresponding volume of DMSO was used as negative control. The plates were incubated at 30°C for 48 hours (M. audouinii and T. rubrum) or 37°C for 24 hours (other organisms). Antimicrobial activity was evaluated by measuring the diameter of the inhibition zone (IZ) around the disc. The assay was repeated twice in duplicate and results were recorded as mean ± SD of the duplicated experiment.
MIC and MMC determinations
The MICs of the crude extract, fractions, compounds 1 and 2 and reference antibiotics (RA) (gentamicin for bacteria and nystatin for fungi) were determined as follows; the test sample was initially dissolved in dimethylsulfoxide (DMSO). The solution obtained was then added to MHB to give a final concentration of 78.12 µg/ml. This was serially diluted two fold to obtain concentration ranges of 0.31 to 78.12 µg/ml. 100 µl of each concentration was 
Results and discussions
The Bio-assay guided fractionation of TSB led to the isolation of three main et al., 2006) and ellagic acid (3) (Grzegorz and Jaromir, 1996) . These compounds together with 3,3'-di-O-methylellagic acid, were lower than that of INH (>39.06 µg/ml). The obtained data highlighted the significant antimycobacterial potency of the two compounds as well as that of the crude extract, fractions TSB6 and TSB7. Results of the MMC determination (Table 3) showed detectable values for fraction TSB7 and compound 1. A keen look of the results in Tables 2 and 3 shows that the recorded MMC values were not more than fourfold their corresponding MICs. This suggests that bactericidal effect of studied samples could be expected (Mims et al. 1993 ). The use of M. smegmatis in this assay was a preliminary step to select the concentration range to be tested on M. tuberculosis species. The results as obtained validated the necessity of such experiment. However, it is well known that the sensitivity of M. smegmatis is closer to that of M. tuberculosis and that this non pathogenic mycobacterial species can be used in selecting samples for M. tuberculosis studies (Newton et al. 2002) . Tables 1 to 3 µg/ml) on T. rubrum, the preceding samples showed equal or greater antifungal effects than nystatin on the four tested fungi. The results of the MMC determinations (Table 3) indicated noticeable values for TSB on 36.4% (4/11) of the tested organisms. This assay also confirmed the interesting activity of fractions 6, 7, compounds 1 and 2. Detectable MMC values were recorded against 90.1% (10/11) of the tested organisms for fraction TSB7, compounds 1 and 2 and against 63.6% (7/11) for fraction TSB6. These data suggest that cidal effect of the tested samples could be expected (Kuete et al. 2007a (Kuete et al. , b, c, 2008 . Furthermore, the activities of the crude extract, fractions 6 and 7 as well as that of the two tested compounds 1 and 2 could be considered as very important since the tested organisms were resistant to commonly used antibiotics. Compounds 1 and 2 appeared to be the main active
principles when considering the microorganisms tested in the present study.
The results from this study are in accordance with previous biological reports on the genus Terminalia. The antimicrobial activity has been demonstrated for a number of Termilia species such as T. catappa (Kloucek et al. 2005) , T. sericea (Steenkamp et al. 2007 ),
T. glaucescens (Magassouba et al. 2007 ) etc. T. chebula ripe seeds extract was found to be active against Staphylocococcus aureus (Bonjar 2004) . Eldeen et al. (2006) demonstrated the antibacterial activity (against both Gram-positive and Gram-negative bacteria) of anolignan B isolated from T. sericea. Some of the bioactive compounds from Terminalia species include 23-galloylarjunolic acid and its β-glucopyranosyl ester, terminolic acid, arjunic acid, arjungenin, arjunglucoside, sericic acid and sericoside isolated from T. macroptera (Conrad et al., 1998) . The present study also identified compounds 1 and 2 as other active principles of the genus Terminalia. Antimicrobial pentacyclic triterpenoids from the stem bark were also identified from this plant (Tabopda et al. 2009 ). Also, compounds 3 (ellagic acid) was reported for its antimicrobial activities on S. aureus, S. epidermidis, Micrococcus luteus, E.
coli, B. subtilis, C. albicans (Cowan 1999; Akiyama et al. 2001; Thiem and Goslinska, 2004 ).
However, this compound was isolated in a limited amount in T. superba and could not be tested in this study. Ellagic acid like-compounds have been found to complex proteins (Scalbert 1991 , Haslam 1996 Stern et al. 1996) , inactivating microbial adhesions, enzymes, cell envelope transport proteins, etc.
The overall results provide promising baseline information for the potential use of the crude extracts from the stem bark of Terminalia superba, fractions 6 and 7 as well as the two tested isolated compounds in the treatment of tuberculosis, and other bacterial and fungal infections. However, this will further be confirmed by pharmacological and toxicological studies currently going on in our laboratory. The Tested samples were crude extract from the stem bark of T. superba (TSB), fractions 1-7 (TSB1-7), 1: 
